Indegene Limited — Investor Meet, 31-07-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Indegene reported Q1 FY26 revenue of INR 760.8 Cr, up 1.8% QoQ in USD, driven by strong client traction and recent deal wins. EBITDA stood at INR 153.6 Cr (20.2% margin) and PAT at INR 116.4 Cr (15.3% margin). Core segments (Enterprise Commercial and Medical Solutions) grew 3.5% QoQ. Management highlighted stable profitable growth, a strong cash position (INR 1,728.0 Cr), and progress on 'Tectonic' engagements, which generated over $1 million revenue. Strategic focus includes M&A, capability enhancement, and sales reorganization for medium to long-term growth. The company maintains a confident outlook.